Annual Accounts Receivable
N/A
December 31, 2023
Summary
- VRDN annual accounts receivable is not available.
Performance
VRDN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
September 30, 2024
Summary
- VRDN quarterly accounts receivable is not available.
Performance
VRDN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
VRDN Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
VRDN Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Viridian Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $57.00 K(-77.0%) |
| Jun 2020 | - | $248.00 K(+6100.0%) |
| Mar 2020 | - | $4000.00(-99.6%) |
| Sep 2019 | - | $979.00 K(+201.2%) |
| Jun 2019 | - | $325.00 K(+5316.7%) |
| Mar 2019 | - | $6000.00(-75.0%) |
| Dec 2018 | $24.00 K(-98.4%) | $24.00 K(-98.3%) |
| Sep 2018 | - | $1.38 M(+15.4%) |
| Jun 2018 | - | $1.20 M(-75.1%) |
| Mar 2018 | - | $4.81 M(+230.3%) |
| Dec 2017 | $1.46 M(+177.9%) | $1.46 M(+129.3%) |
| Sep 2017 | - | $635.00 K(+17.8%) |
| Jun 2017 | - | $539.00 K(+94.6%) |
| Mar 2017 | - | $277.00 K(-47.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $524.00 K(+33.0%) | $524.00 K(-28.5%) |
| Sep 2016 | - | $733.00 K(+11.4%) |
| Jun 2016 | - | $658.00 K(+34.3%) |
| Mar 2016 | - | $490.00 K(+24.4%) |
| Dec 2015 | $394.00 K(-63.8%) | $394.00 K(-28.0%) |
| Sep 2015 | - | $547.00 K(-5.9%) |
| Jun 2015 | - | $581.00 K(-2.8%) |
| Mar 2015 | - | $598.00 K(-45.0%) |
| Dec 2014 | $1.09 M(+9.5%) | $1.09 M(-29.8%) |
| Sep 2014 | - | $1.55 M(+14.0%) |
| Jun 2014 | - | $1.36 M(+15.8%) |
| Mar 2014 | - | $1.17 M(+18.1%) |
| Dec 2013 | $994.00 K(-16.9%) | $994.00 K |
| Dec 2012 | $1.20 M | - |
FAQ
- What is the all time high annual accounts receivable for Viridian Therapeutics?
- What is the all time high quarterly accounts receivable for Viridian Therapeutics?
What is the all time high annual accounts receivable for Viridian Therapeutics?
Viridian Therapeutics all-time high annual accounts receivable is $1.46 M
What is the all time high quarterly accounts receivable for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly accounts receivable is $4.81 M